Raytheon Technologies Corporation Profile Avatar - Palmy Investing

Raytheon Technologies Corporation

Raytheon Technologies Corporation, an aerospace and defense company, provides systems and services for the commercial, military, and government customers worldwide. It operates through four segments: Collins Aerospace Systems, Pratt & Whitney, Raytheon I…

Aerospace & Defense
US, Waltham [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 44.49 65.94 45.64
Graham Fair Price 12.21 36.28 32.33
PEG 958.77 0.83 -0.08
Price/Book 12.71 2.15 1.91
Price/Cash Flow 1361.03 -451.26 30.89
Prices/Earnings -4.88 19.01 19.99
Price/Sales 17.67 6.73 5.72
Price/FCF 1361.03 -451.26 30.89
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -8.31 0.18 0.20
Operating Margin -12.98 0.08 0.09
ROA 21.10 0.01 < 0.005
ROE 0.02 0.03 18.48
ROIC 0.01 0.01 -4.95
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.02 0.23 -90.53
Dividends QOQ -0.02 0.02 0.34
EBIT QOQ 2.27 -0.16 -93.09
EPS QOQ 2.54 0.23 -91.02
FCF QOQ 0.46 -1.08 134.92
Revenue QOQ 0.48 -0.03 -93.50
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 66.59 70.80 6.33
Days Sales Outstanding (DSO) 103.78 109.02 5.05
Inventory Turnover 1.35 1.27 -5.96
Debt/Capitalization 0.43 0.41 -3.73
Quick Ratio 0.63 0.64 1.86
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 44.13 45.50 3.09
Cash 4.86 4.22 -13.25
Capex -0.75 -0.47 37.05
Free Cash Flow 2.72 -0.22 -92.05
Revenue 14.71 14.52 -1.26
Naive Interpretation member
05 - Per Share Metrics · Bad
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.04 1.07 3.02
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 11.56 15.11 30.80
Naive Interpretation Member
06 - Financial Health · Bad
End of RTX's Analysis
CIK: 101829 CUSIP: 75513E101 ISIN: US75513E1010 LEI: - UEI: -
Secondary Listings
RTX has no secondary listings inside our databases.